TSOI - Therapeutic Solutions International, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Therapeutic Solutions International, Inc.

4093 Oceanside Boulevard
Suite B
Oceanside, CA 92056
United States

Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy George DixonChairman, CEO, Pres & Member of CTE Advisory Board174kN/A1958
Mr. Gerry B. BergVP, CFO & Director174kN/A1947
Dr. Feng LinChief Scientific OfficerN/AN/AN/A
Dr. James Drew VeltmeyerChief Medical Officer, Vice Chairman of CTE Advisory Board & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health. Its flagship product is ProJuvenol, a synergistic blend of complex anti-aging ingredients based upon pterostilbene to promote cellular rejuvenation and healthy functionality. The company also focuses on the manufacture of devices to treat patients with obstructive sleep apnea. Therapeutic Solutions International, Inc. was founded in 2010 and is based in Oceanside, California.

Corporate Governance

Therapeutic Solutions International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.